VIRAL-INFECTIONS TRIGGER MULTIPLE-SCLEROSIS RELAPSES - A PROSPECTIVE SEROEPIDEMIOLOGICAL STUDY

被引:217
作者
ANDERSEN, O
LYGNER, PE
BERGSTROM, T
ANDERSSON, M
VAHLNE, A
机构
[1] GOTHENBURG UNIV, DEPT NEUROL, S-41345 GOTHENBURG, SWEDEN
[2] GOTHENBURG UNIV, DEPT VIROL, S-41345 GOTHENBURG, SWEDEN
关键词
MULTIPLE SCLEROSIS; VIRAL INFECTION; EPIDEMIOLOGY; ADENOVIRUS;
D O I
10.1007/BF00867354
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A neurological surveillance was combined with prospective recording of upper respiratory and gastrointestinal infections and serological diagnosis of five common viral infections in 60 benign multiple sclerosis patients, with a mean follow-up of 31 months. During 4-week at risk (AR) periods encompassing common infections, a significant excess of MS relapses was found in the AR period, with a relative risk of 1.3. A seasonal variation of the MS relapse rate was found with a minimum in summer. There was a significant correlation between the number of AR relapses and the number of common infections per month explaining the periannual distribution of relapses. The non-AR relapses showed no seasonal variation. There was a significant correlation between adenovirus CF titre rises associated with upper respiratory infections and the occurrence of a major MS relapse in the AR period (n = 7), while influenza infections were not followed by a major MS relapse (n = 6). Linear homologies have been demonstrated between adenovirus and basic myelin protein. The epidemiological approach is essential to our understanding of systemic antigens triggering multiple sclerosis activity.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 28 条
  • [11] SEQUENCE HOMOLOGY BETWEEN CERTAIN VIRAL-PROTEINS AND PROTEINS RELATED TO ENCEPHALOMYELITIS AND NEURITIS
    JAHNKE, U
    FISCHER, EH
    ALVORD, EC
    [J]. SCIENCE, 1985, 229 (4710) : 282 - 284
  • [12] KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
  • [13] Kurtzke JF, 1970, HDB CLINICAL NEUROLO, P161
  • [14] MARTENSSON E, 1980, CURR THER RES CLIN E, V28, P767
  • [15] MERCK C, 1983, ACTA PATH MICRO IM A, V91, P1
  • [16] NORRBY E, 1970, P SOC EXP BIOL MED, V134, P889, DOI 10.3181/00379727-134-34905
  • [17] PANITCH HS, 1991, J NEUROIMMUNOL S, V1, P125
  • [18] NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS
    POSER, CM
    PATY, DW
    SCHEINBERG, L
    MCDONALD, WI
    DAVIS, FA
    EBERS, GC
    JOHNSON, KP
    SIBLEY, WA
    SILBERBERG, DH
    TOURTELLOTTE, WW
    [J]. ANNALS OF NEUROLOGY, 1983, 13 (03) : 227 - 231
  • [19] SALMI A, 1983, CLIN EXP IMMUNOL, V52, P241